VIVANI MEDICAL INC (VANI) Forecast, Price Target & Analyst Ratings

NASDAQ:VANIUS92854B1098

Current stock price

1.08 USD
+0.08 (+8%)
At close:
1.06 USD
-0.02 (-1.85%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIVANI MEDICAL INC (VANI).

Forecast Snapshot

Consensus Price Target

Price Target
$5.61
+ 419.44% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.61
Upside
+ 419.44%
From current price of $1.08 to mean target of $5.61, Based on 9 analyst forecasts
Low
$4.04
Median
$5.61
High
$7.35

Price Target Revisions

1 Month
10.00%
3 Months
10.00%

Price Target Summary

9 Wall Street analysts provided a forecast for the next 12 months for VANI. The average price target is 5.61 USD. This implies a price increase of 419.44% is expected in the next year compared to the current price of 1.08.
The average price target has been revised upward by 10% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

VANI Current Analyst RatingVANI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

VANI Historical Analyst RatingsVANI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
VANI was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about VANI.
In the previous month the buy percentage consensus was at a similar level.
VANI was analyzed by 9 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-31HC Wainwright & Co.Maintains Buy -> Buy
2025-09-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-19HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-04-04HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-07HC Wainwright & Co.Initiate Buy
2022-12-05ThinkEquityInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
25.82%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

VANI is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2025 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VANI revenue by date.VANI revenue by date.
7.96M
99.50%
6.9M
-13.32%
3.38M
-51.01%
2.635M
-100.00%
2.073M18.327M52.283M
185.28%
74.381M
42.27%
110.43M
48.47%
451.73M
309.06%
EBITDA
YoY % growth
VANI ebitda by date.VANI ebitda by date.
-28.15M
14.12%
-34.18M
-21.42%
-30.19M
11.67%
-30.874M
58.56%
-28.66M
29.18%
-14.28M
-135.44%
-20.4M
-27.56%
-23.46M
7.55%
-23.46M
4.63%
-23.46M-38.76M
-65.22%
-92.82M
-139.47%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
VANI ebit by date.VANI ebit by date.
-28.61M
13.85%
-34.62M
-21.01%
-30.59M
11.64%
-31.323M
58.58%
-29.133M
29.52%
-20.4M
-137.85%
-28.467M
-26.95%
-24.843M
7.29%
-27.806M
-11.22%
-29.382M
-5.67%
-35.142M
-19.60%
-30.911M
12.04%
-10.366M
66.46%
18.501M
278.47%
34.962M
88.97%
64.78M
85.29%
354.02M
446.50%
Operating Margin
VANI operating margin by date.VANI operating margin by date.
-359.42%-501.74%-905.03%-1,188.64%-1,405.45%N/AN/AN/AN/AN/AN/AN/A-56.56%35.39%47.00%58.66%78.37%
EPS
YoY % growth
VANI eps by date.VANI eps by date.
N/A
28.99%
N/A
5.45%
-6.54
48.62%
-8.39
-28.36%
-10.58
-26.04%
-0.27
97.49%
-0.54
-103.85%
-0.43
18.61%
-0.42
4.95%
-0.36
14.63%
-0.49
-37.14%
-0.91
-85.42%
N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.08
25.82%
-0.08
32.00%
-0.07
35.09%
-0.07
20.67%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-7M
-6.75%
-7.095M
4.92%
-7.366M
-9.53%
-7.526M
-10.51%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VANI Yearly Revenue VS EstimatesVANI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2029 2030 2031 2032 2033 100M 200M 300M 400M
VANI Yearly EPS VS EstimatesVANI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-3.62%
EPS Next 5 Year
-19.85%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-15.98%
EBIT Next 5 Year
-39.03%

VIVANI MEDICAL INC / VANI Forecast FAQ

What do analysts expect the price target to be for VIVANI MEDICAL INC (VANI)?

9 analysts have analysed VANI and the average price target is 5.61 USD. This implies a price increase of 419.44% is expected in the next year compared to the current price of 1.08.

What is the next earnings date for VANI stock?

VIVANI MEDICAL INC (VANI) will report earnings on 2026-05-11.

What are the consensus estimates for VIVANI MEDICAL INC (VANI) next earnings?

The consensus EPS estimate for the next earnings of VIVANI MEDICAL INC (VANI) is -0.08 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for VANI stock?

The number of analysts covering VIVANI MEDICAL INC (VANI) is 9.